Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT05890365)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT05890365 Sponsor: Steno Diabetes Center Copenhagen Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05890365 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who were born with a low birth weight (in the bottom 10% compared to the general population) — 250 participants with low birth weight are being recruited, along with 50 participants born with a normal birth weight (between the 50th and 90th percentile) as a comparison group
People who were born full-term, between 39 and 41 weeks of pregnancy
Both men and women are eligible
Participants must be healthy

Who may not be able to join:

People with a Body Mass Index (BMI) over 35 (a measure of body weight relative to height)
People who have a disease or take medication that is known to affect the main thing being measured in this trial (confirm with trial site)
People who describe themselves as having a high level of physical activity
People who drink more alcohol than general health guidelines recommend
People who have a metabolic condition or liver disease
People whose weight has changed by more than 3 kg (about 6.6 pounds) in the past 6 months, whether gained or lost

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Allan Vaag, MD, PhD, Steno Diabetes Center Copenhagen

Phone: +4526129093

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05890365

Sponsor: Steno Diabetes Center Copenhagen

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: +4526129093

More information: https://clinicaltrials.gov/study/NCT05890365

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who were born with a low birth weight (in the bottom 10% compared to the general population) — 250 participants with low birth weight are being recruited, along with 50 participants born with a normal birth weight (between the 50th and 90th percentile) as a comparison group
People who were born full-term, between 39 and 41 weeks of pregnancy
Both men and women are eligible
Participants must be healthy

Who may not be able to join:

People with a Body Mass Index (BMI) over 35 (a measure of body weight relative to height)
People who have a disease or take medication that is known to affect the main thing being measured in this trial (confirm with trial site)
People who describe themselves as having a high level of physical activity
People who drink more alcohol than general health guidelines recommend
People who have a metabolic condition or liver disease
People whose weight has changed by more than 3 kg (about 6.6 pounds) in the past 6 months, whether gained or lost

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Steno Diabetes Center Copenhagen

Registry

ClinicalTrials.gov

Start date

14 December 2023

Est. completion

1 June 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Liver fat content

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov